LANTHEUS HOLDINGS, INC. (LNTH)
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
CSPi Reports FY2026 Third Quarter Results
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
Suncrete Announces Q2 2026 Earnings Results
INVESTOR ALERT: GPGI, Inc. (GPGI) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Wells Fargo & Company Declares Cash Dividends on Preferred Stock
Evolv Technology Expands Market Reach and Deepens Customer Adoption as Demand for AI-Powered Security Remains Strong
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
Net Asset Value(s)
JinkoSolar to Report Second Quarter 2026 Results on August 26, 2026